“More pharmaceutical
companies are buying drugs that they see as undervalued, then raising the
prices. It is one of a number of industry tactics, along with companies
regularly upping the prices of their own older medicines and launching new
treatments at once unheard of sums, driving up the cost of drugs.”
(Jonathan D. Rockoff and Ed Silverman, The Wall Street
Journal)
No comments:
Post a Comment